4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-013484
Chief Scientific Officer sold 17,446 shares at an average $41.48 ($723,625)
From the SEC's structured data for this filing
Trades in this filing
Leen Ann M. · Chief Scientific Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-19 | Sale : show line 1 in the form | −7,541 | $41.75 | $314,868 | 2,481,590 | I |
| 2021-02-22 | Sale : show line 2 in the form | −1,200 | $41.54 | $49,846 | 2,480,390 | I |
| 2021-02-22 | Sale : show line 3 in the form | −4,506 | $42.84 | $193,034 | 2,475,884 | I |
| 2021-02-23 | Sale : show line 4 in the form | −1,492 | $38.83 | $57,931 | 2,474,392 | I |
| 2021-02-23 | Sale : show line 5 in the form | −1,907 | $39.59 | $75,498 | 2,472,485 | I |
| 2021-02-23 | Sale : show line 6 in the form | −800 | $40.56 | $32,448 | 2,471,685 | I |
| Open-market sales · 17,446 sh · avg $41.48 · $723,625 | ||||||
Loading xslF345X03/doc4.xml…